All posts from Zacks
Zacks in Our Research. Your Success.,

Haemonetics (HAE) in Focus: Stock Moves 10% Higher

Haemonetics Corporation HAE was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $44.96–$47.88 in the past one-month time frame, witnessed a sharp increase yesterday.

The shares rose after the company reported better-than-expected second quarter and first Half Fiscal 2018 results

The company has seen no estimate revisions over the past one month, and the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.     

Haemonetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Haemonetics Corporation Price and Consensus

Haemonetics Corporation Price and Consensus | Haemonetics Corporation Quote

A better ranked stock in the  Medical - Products industry is Terumo Corp.TRUMY which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is HAE going up? Or down? Predict to see what others think: Up or Down

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Haemonetics Corporation (HAE): Free Stock Analysis Report
Terumo Corp. (TRUMY): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research